Neonates with confirmed or suspected invasive candidiasis. Neonates who are at high risk of fungal infections due to prolonged use of broad-spectrum antibiotics, central venous catheters, or parenteral nutrition. Patients who are not responding to other antifungal therapies or have contraindications to other treatments.